Journal
MOLECULAR CELL
Volume 44, Issue 2, Pages 265-278Publisher
CELL PRESS
DOI: 10.1016/j.molcel.2011.07.037
Keywords
-
Categories
Funding
- Science Foundation Ireland [07/SRC/B1144, 08/IN.1/82031]
- Wellcome Trust UK [082749]
Ask authors/readers for more resources
Granzyme B is a cytotoxic lymphocyte-derived protease that plays a central role in promoting apoptosis of virus-infected target cells, through direct proteolysis and activation of constituents of the cell death machinery. However, previous studies have also implicated granzymes A and B in the production of proinflammatory cytokines, via a mechanism that remains undefined. Here we show that IL-1 alpha is a substrate for granzyme B and that proteolysis potently enhanced the biological activity of this cytokine in vitro as well as in vivo. Consistent with this, compared with full-length IL-1 alpha, granzyme B-processed IL-1 alpha exhibited more potent activity as an immunoadjuvant in vivo. Furthermore, proteolysis of IL-1 alpha within the same region, by proteases such as calpain and elastase, was also found to enhance its biological potency. Thus, IL-1 alpha processing by multiple immune-related proteases, including granzyme B, acts as a switch to enhance the proinflammatory properties of this cytokine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available